Evidence map›Paper›PMID 28576690›Full record

ArticleDevelopmental biology2017

Complement component C3aR constitutes a novel regulator for chick eye morphogenesis.

Erika Grajales-Esquivel, Agustin Luz-Madrigal, Jeffrey Bierly, Tracy Haynes, Edimara S Reis, Zeyu Han, Christian Gutierrez, Zachary McKinney, Apostolia Tzekou, John D Lambris and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Developmental biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Erika Grajales-EsquivelDepartment of Biology, Miami University and Center for Visual Sciences at Miami University (CVSMU), Oxford, OH 45056, USA. Electronic address: esquiveg@miamioh.edu.
Agustin Luz-MadrigalDepartment of Biology, Miami University and Center for Visual Sciences at Miami University (CVSMU), Oxford, OH 45056, USA; Department of Biology, University of Dayton and Center for Tissue Regeneration and Engineering at the University of Dayton (TREND), Dayton, OH 45469, USA. Electronic address: madrigal@miamioh.edu.
Jeffrey BierlyDepartment of Biology, Miami University and Center for Visual Sciences at Miami University (CVSMU), Oxford, OH 45056, USA. Electronic address: bierlyjj@miamioh.edu.
Tracy HaynesDepartment of Biology, Miami University and Center for Visual Sciences at Miami University (CVSMU), Oxford, OH 45056, USA. Electronic address: haynest@miamioh.edu.
Edimara S ReisDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: edireis@mail.med.upenn.edu.
Zeyu HanDepartment of Biology, Miami University and Center for Visual Sciences at Miami University (CVSMU), Oxford, OH 45056, USA. Electronic address: hanz2@miamioh.edu.
Christian GutierrezDepartment of Biology, Miami University and Center for Visual Sciences at Miami University (CVSMU), Oxford, OH 45056, USA. Electronic address: gutierc@miamioh.edu.
Zachary McKinneyDepartment of Biology, Miami University and Center for Visual Sciences at Miami University (CVSMU), Oxford, OH 45056, USA. Electronic address: mckinnzj@miamioh.edu.
Apostolia TzekouDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: a.tzekou@gmail.com.
John D LambrisDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: lambris@upenn.edu.
Panagiotis A TsonisDepartment of Biology, University of Dayton and Center for Tissue Regeneration and Engineering at the University of Dayton (TREND), Dayton, OH 45469, USA. Electronic address: ptsonis1@udayton.edu.
Katia Del Rio-TsonisDepartment of Biology, Miami University and Center for Visual Sciences at Miami University (CVSMU), Oxford, OH 45056, USA. Electronic address: delriok@miamioh.edu.
Miami University · USUniversity of Pennsylvania · USUniversity of Dayton · US

Funding

Role of complement in kidney disorders: from hemodialysis to transportationP01AI068730 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 2007 to 2018
$16.0M
GENE REGULATION IN LENS REGENERATIONR01EY010540 · NEI · UNIVERSITY OF DAYTON · PI TSONIS, PANAGIOTIS A · 1995 to 2013
$3.3M
Complement in AMD: Mechanisms and Therapeutic InterventionR01EY020633 · NEI · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 2011 to 2013
$1.8M
The role of Injury signals in RPE ReprogrammingR01EY026816 · NEI · MIAMI UNIVERSITY OXFORD · PI DEL RIO-TSONIS, KATIA · 2016 to 2020
$1.8M
Signaling pathways during chick retina regenerationR01EY017319 · NEI · MIAMI UNIVERSITY OXFORD · PI DEL RIO-TSONIS, KATIA · 2007 to 2011
$1.4M
NEI NIH HHS R01 EY010540NEI NIH HHS R01 EY017319NEI NIH HHS R01 EY020633NEI NIH HHS R01 EY026816NIAID NIH HHS P01 AI068730
6 · The paper itself

Abstract

Complement components have been implicated in a wide variety of functions including neurogenesis, proliferation, cell migration, differentiation, cancer, and more recently early development and regeneration. Following our initial observations indicating that C3a/C3aR signaling induces chick retina regeneration, we analyzed its role in chick eye morphogenesis. During eye development, the optic vesicle (OV) invaginates to generate a bilayer optic cup (OC) that gives rise to the retinal pigmented epithelium (RPE) and neural retina. We show by immunofluorescence staining that C3 and the receptor for C3a (the cleaved and active form of C3), C3aR, are present in chick embryos during eye morphogenesis in the OV and OC. Interestingly, C3aR is mainly localized in the nuclear compartment at the OC stage. Loss of function studies at the OV stage using morpholinos or a blocking antibody targeting the C3aR (anti-C3aR Ab), causes eye defects such as microphthalmia and defects in the ventral portion of the eye that result in coloboma. Such defects were not observed when C3aR was disrupted at the OC stage. Histological analysis demonstrated that microphthalmic eyes were unable to generate a normal optic stalk or a closed OC. The dorsal/ventral patterning defects were accompanied by an expansion of the ventral markers Pax2, cVax and retinoic acid synthesizing enzyme raldh-3 (aldh1a3) domains, an absence of the dorsal expression of Tbx5 and raldh-1 (aldh1a1) and a re-specification of the ventral RPE to neuroepithelium. In addition, the eyes showed overall decreased expression of Gli1 and a change in distribution of nuclear β-catenin, suggesting that Shh and Wnt pathways have been affected. Finally, we observed prominent cell death along with a decrease in proliferating cells, indicating that both processes contribute to the microphthalmic phenotype. Together our results show that C3aR is necessary for the proper morphogenesis of the OC. This is the first report implicating C3aR in eye development, revealing an unsuspected hitherto regulator for proper chick eye morphogenesis.

Indexed as

Gene Expression Regulation, DevelopmentalAldehyde DehydrogenaseAnimalsApoptosisbeta CateninBody PatterningCell ProliferationChick EmbryoComplement C3aHedgehog ProteinsMicrophthalmosMorphogenesisPAX2 Transcription FactorReceptors, ComplementRetinal DehydrogenaseRetinal Pigment EpitheliumAldehyde Dehydrogenasebeta CateninComplement C3acomplement C3a receptorHedgehog ProteinsPAX2 Transcription FactorReceptors, ComplementRetinal DehydrogenaseT-Box Domain ProteinsT-box transcription factor 5Zinc Finger Protein GLI1C3C3aRColobomaComplementEye developmentMicrophthalmiaOptic vesicle

Identifiers

PMID28576690
PMCPMC5726978
OpenAlexW2620134376

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.